Suppr超能文献

膳食蛋白质、血管紧张素I转换酶抑制及系膜超负荷对阿霉素诱导的肾病进展的影响。

Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.

作者信息

Barretti P, Viero R M, Soares V A

机构信息

Departamento de Clínica Médica, Faculdade de Medicina, Universidade Estadual Paulista, Botucatu, Brasil.

出版信息

Braz J Med Biol Res. 1995 Jan;28(1):39-50.

PMID:7581027
Abstract

Adriamycin, a commonly used antineoplastic antibiotic, induces glomerular lesions in rats, resulting in persistent proteinuria and glomerulosclerosis. We studied the effects of dietary protein and of an angiotensin I converting enzyme inhibitor on the progression of this nephropathy and the evolution of the histological lesions, as well as mesangial macromolecule flow. Adriamycin nephropathy was induced by injecting a single iv dose of adriamycin (3 mg/kg body weight) into the tail vein of male Wistar rats (weight, 180-200 g). In Experiment I animals with adriamycin-induced nephropathy were fed diets containing 6% (Low-Protein Diet Group = LPDG), 20% (Normal-Protein Diet Group = NPDG) and 40% (High-Protein Diet Group = HPDG) protein and were observed for 30 weeks. In Experiment II the rats with adriamycin nephropathy were divided into 2 groups: ADR, that received adriamycin alone, and ADR-ENA, that received adriamycin plus enalapril, an angiotensin I converting enzyme inhibitor. The animals were sacrificed after a 24-week observation period. Six hours before sacrifice the animals were injected with 131I-ferritin and the amount of 131I-ferritin in the glomeruli was measured. In Experiment III, renal histology was performed 4, 8 and 16 weeks after adriamycin injection. At the end of Experiment I the tubulointerstitial lesion index was 2 for LPDG, 8 for NPDG, and 7.5 for HPDG (P < 0.05); the frequency of glomerulosclerosis was 19 +/- 6.1% in LPDG, 42.6 +/- 6% in NPDG, and 54 +/- 9% in HPDG (P < 0.05); and proteinuria was 61.1 +/- 25 mg/24 h in LPDG, 218.7 +/- 27.5 mg/24 h in NPDG, and 324.5 +/- 64.8 mg/24 h in HPDG (P < 0.05). In Experiment II, at sacrifice, 24-h proteinuria was 189 +/- 16.1 mg in ADR, and 216 +/- 26.1 mg in ADR-ENA (P > 0.05); the tubulointerstitial lesion index was 5 for ADR, and 5 for ADR-ENA (P > 0.05); the frequency of glomerulosclerosis was 40 +/- 5.2% in ADR and 44 +/- 6% in ADR-ENA (P > 0.05); the amount of 131I-ferritin in the mesangium was 214.26 +/- 22.71 cpm/mg protein in ADR and 253.77 +/- 69.72 cpm/mg protein in ADR-ENA (P > 0.05). In Experiment III, sequential histological analysis revealed an acute tubulointerstitial cellular infiltrate at week 4, which was decreased at week 8. Tubular casts and dilatation were first seen at week 8 and increased at week 16 when few glomerular lesions were found.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

阿霉素是一种常用的抗肿瘤抗生素,可诱导大鼠出现肾小球病变,导致持续性蛋白尿和肾小球硬化。我们研究了饮食蛋白质和一种血管紧张素I转换酶抑制剂对这种肾病进展、组织学病变演变以及系膜大分子流动的影响。通过向雄性Wistar大鼠(体重180 - 200克)尾静脉单次静脉注射阿霉素(3毫克/千克体重)诱导阿霉素肾病。在实验I中,给患有阿霉素诱导肾病的动物喂食含6%(低蛋白饮食组 = LPDG)、20%(正常蛋白饮食组 = NPDG)和40%(高蛋白饮食组 = HPDG)蛋白质的饮食,并观察30周。在实验II中,将患有阿霉素肾病的大鼠分为2组:ADR组,仅接受阿霉素;ADR - ENA组,接受阿霉素加血管紧张素I转换酶抑制剂依那普利。观察24周后处死动物。处死前6小时给动物注射131I - 铁蛋白,并测量肾小球中131I - 铁蛋白的量。在实验III中,在注射阿霉素后4周、8周和16周进行肾脏组织学检查。在实验I结束时,LPDG组的肾小管间质病变指数为2,NPDG组为8,HPDG组为7.5(P < 0.05);LPDG组肾小球硬化频率为19±6.1%,NPDG组为42.6±6%,HPDG组为54±9%(P < 0.05);LPDG组蛋白尿为61.1±25毫克/24小时,NPDG组为218.7±27.5毫克/24小时,HPDG组为324.5±64.8毫克/24小时(P < 0.05)。在实验II中,处死时,ADR组24小时蛋白尿为189±16.1毫克,ADR - ENA组为216±26.1毫克(P > 0.05);ADR组肾小管间质病变指数为5,ADR - ENA组为5(P > 0.05);ADR组肾小球硬化频率为40±5.2%,ADR - ENA组为44±6%(P > 0.05);ADR组系膜中131I - 铁蛋白量为214.26±22.71计数/分钟/毫克蛋白,ADR - ENA组为253.77±69.72计数/分钟/毫克蛋白(P > 0.05)。在实验III中,连续组织学分析显示第4周出现急性肾小管间质细胞浸润,第8周减少。肾小管管型和扩张在第8周首次出现,第16周增加,此时肾小球病变较少。(摘要截于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验